Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?
Repetitive element hypermethylation in multiple sclerosis patients.
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures.
Role of FET proteins in neurodegenerative disorders.
Intracellular ion signaling influences myelin basic protein synthesis in oligodendrocyte precursor cells.
Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.
Genetic evidence for a role of the SREBP transcription system and lipid biosynthesis in schizophrenia and antipsychotic treatment.
A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA.
Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis.
Measuring Brain Tissue Integrity during 4 Years Using Diffusion Tensor Imaging.
Systemic lupus erythematosus: molecular cloning and analysis of recombinant monoclonal kappa light chain NGTA1-Me-pro with two metalloprotease active centers.
How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study.
[Value of electroencephalography in the early detection of neonatal leucinosis].
Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.
Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.
Recent updates on molecular genetic engineering approaches and applications of human therapeutic proteins.
Orofacial evaluation in patients with multiple sclerosis using Nordic Orofacial Test-Screening.
Treatment for Krabbe's disease: Finding the combination.
The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis.
Comparison of Quantitative Cerebral Blood Flow Measurements Performed by Bookend Dynamic Susceptibility Contrast and Arterial Spin-Labeling MRI in Relapsing-Remitting Multiple Sclerosis.
Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia.
Adipose stromal vascular fraction-mediated improvements at late-stage disease in a murine model of multiple sclerosis.
Autoantibody-mediated encephalitis: Not just paraneoplastic, not just limbic, and not untreatable.
Structural brain indices and executive functioning in multiple sclerosis: A review.
Interfering with the CCL2-glycosaminoglycan axis as a potential approach to modulate neuroinflammation.
Pages
« first
‹ previous
…
808
809
810
811
812
813
814
815
816
…
next ›
last »